VCEL
Vericel Corporation
Nasdaq · usd
Vericel Corporation (VCEL) trades at $54.62 (+5.49%) as of 7:30:03 PM EST on Nov 6, 2026, +36.38% over the past month. Market cap is $2.79B, with 9.5 days to cover in short interest.
Stock performance
How Vericel Corporation (VCEL) stock has performed from one day to one year, with its 52-week range.
- 1D
- +5.48%
- 1W
- +35.67%
- 1M
- +36.38%
- YTD
- +51.68%
- 1Y
- +40.09%
- 52-wk range
- $28.95 – $55.60
Key statistics
Today's trading snapshot for VCEL: day range, open, previous close, volume and market cap.
- Day range
- $50.76 – $54.64
- Open
- $51.79
- Prev close
- $51.78
- Volume
- 1.62M
- Market cap
- $2.79B
- Shares out
- 51.21M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Vericel Corporation: P/E, P/S, P/B, ROE and more.
- P/E
- 109.47
- P/S
- 8.66
- P/B
- 7.17
- P/FCF
- 43.00
- ROE
- 6.6%
- ROA
- 4.8%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 5, 2026
8-K filings
Material corporate events Vericel Corporation has disclosed to the SEC on Form 8-K.
- Guidance issuance or updateNov 5, 2026
Exhibit 99.1 is described as the press release of Vericel Corporation, "Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial Guidance."
- Guidance issuance or updateJul 30, 2026
Press Release of Vericel Corporation, 'Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program'
- Bylaw amendmentMay 18, 2026
Effective May 18, 2026, the Board of Directors of Vericel Corporation, a Michigan corporation (the "Company"), approved an amendment to the Company's bylaws. The amendment accounts for the change in the address of the Company's principal executive offices as a result of its move to a new global headquarters, located at 25 Blue Sky Drive, Burlington, Massachusetts 01803.
- Guidance issuance or updateMay 7, 2026
Press Release of Vericel Corporation, 'Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance'
- Preliminary resultsJan 13, 2026
the Company issued a press release, which includes estimates of operating and financial results, including its estimated, preliminary and unaudited full-year revenue for fiscal year 2025, preliminary and unaudited net income for 2025, preliminary and unaudited 2025 gross margin percentage, preliminary 2025 adjusted EBITDA margin, its estimated cash and investments balance as of December 31, 2025
Dividend history and stock splits
Vericel Corporation's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-20Oct 16, 2013
VCEL short interest
How heavily VCEL is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 9.5
- Short interest
- 5.24M
- Avg volume
- 550.01K
As of · reported to FINRA twice monthly.
VCEL news
The latest news and headlines about Vericel Corporation (VCEL).
- Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase ProgrampositiveGlobeNewswire Inc.· Jul 30, 2026
- Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsightpositiveGlobeNewswire Inc.· May 5, 2026
- Vericel Announces Preliminary 2025 Financial Results and Business UpdatespositiveGlobeNewswire Inc.· Jan 13, 2026
- Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports EarningsneutralThe Motley Fool· Nov 6, 2025
- MediWound Revenue Jumps 43% in Q2positiveThe Motley Fool· Aug 14, 2025
Frequently asked questions
What is the Vericel Corporation (VCEL) stock price today?
Vericel Corporation (VCEL) is trading at $54.62 (+5.49% on the day) as of 7:30:03 PM EST on Nov 6, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Vericel Corporation?
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen…
What is the short interest in VCEL?
As of Oct 15, 2026, VCEL has 5.24M shares short and 9.5 days to cover.
What exchange is VCEL listed on?
Vericel Corporation (VCEL) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.
Build with AI
Build an analysis of VCEL with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a VCEL analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.